← Back
$MURA All transactions

Mural Oncology plc

D

$ Value

Shares

134,225

Price

Filed

Dec 5

Insider

Name

Loew Caroline

Title

Chief Executive Officer

CIK

0001989488

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-05

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Pursuant to the terms of the Transaction Agreement (the "Agreement"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. ("Sub"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, Sub acquired all the issued and to be issued share capital of the Issuer (the "Acquisition") for a cash purchase price of $2.035 per share (the "Scheme Consideration"), as of December 5, 2025 (the "Effective Time"). | Includes the disposition of 220,148 unvested restricted stock units ("RSUs"). Pursuant to the Agreement, as of the Effective Time each RSU held by the Reporting Person that was outstanding as of immediately prior to the Effective Time (whether or not vested) was automatically cancelled and converted into the right to receive an amount equal to the Scheme Consideration. | Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options.

Filing Info

Accession No.

0001193125-25-308787

Form Type

4

Issuer CIK

0001971543

Loew Caroline's History

Date Ticker Type Value
2025-12-05 MURA D
2025-12-05 MURA D
2025-12-05 MURA D
2025-12-05 MURA D
2025-07-07 MURA $30K

Other Insiders at MURA (90d)

No other insider activity at this issuer in the last 90 days.